BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 15180965)

  • 1. Prostaglandin E2 induces IL-23 production in bone marrow-derived dendritic cells.
    Sheibanie AF; Tadmori I; Jing H; Vassiliou E; Ganea D
    FASEB J; 2004 Aug; 18(11):1318-20. PubMed ID: 15180965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E2 and tumor necrosis factor alpha cooperate to activate human dendritic cells: synergistic activation of interleukin 12 production.
    Rieser C; Böck G; Klocker H; Bartsch G; Thurnher M
    J Exp Med; 1997 Nov; 186(9):1603-8. PubMed ID: 9348319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E2 inhibits IL-23 and IL-12 production by human monocytes through down-regulation of their common p40 subunit.
    Kalim KW; Groettrup M
    Mol Immunol; 2013 Mar; 53(3):274-82. PubMed ID: 22982753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin E2-induced IL-23p19 subunit is regulated by cAMP-responsive element-binding protein and C/AATT enhancer-binding protein β in bone marrow-derived dendritic cells.
    Kocieda VP; Adhikary S; Emig F; Yen JH; Toscano MG; Ganea D
    J Biol Chem; 2012 Oct; 287(44):36922-35. PubMed ID: 22977257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production.
    Vaknin-Dembinsky A; Balashov K; Weiner HL
    J Immunol; 2006 Jun; 176(12):7768-74. PubMed ID: 16751425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine production by mouse myeloid dendritic cells in relation to differentiation and terminal maturation induced by lipopolysaccharide or CD40 ligation.
    Morelli AE; Zahorchak AF; Larregina AT; Colvin BL; Logar AJ; Takayama T; Falo LD; Thomson AW
    Blood; 2001 Sep; 98(5):1512-23. PubMed ID: 11520802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and regulation of interleukin-23 subunits in human peripheral blood mononuclear cells and hematopoietic cell lines in response to various inducers.
    Ma XT; Zhang XJ; Zhang B; Geng YQ; Lin YM; Li G; Wu KF
    Cell Biol Int; 2004; 28(10):689-97. PubMed ID: 15516327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epinephrine-primed murine bone marrow-derived dendritic cells facilitate production of IL-17A and IL-4 but not IFN-γ by CD4+ T cells.
    Kim BJ; Jones HP
    Brain Behav Immun; 2010 Oct; 24(7):1126-36. PubMed ID: 20621581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells.
    Strengell M; Lehtonen A; Matikainen S; Julkunen I
    J Leukoc Biol; 2006 Jun; 79(6):1279-85. PubMed ID: 16551679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of virus-induced IL-12 and IL-23 expression in human macrophages.
    Pirhonen J; Matikainen S; Julkunen I
    J Immunol; 2002 Nov; 169(10):5673-8. PubMed ID: 12421946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-beta differentially regulates expression of the IL-12 family members p35, p40, p19 and EBI3 in activated human dendritic cells.
    van Seventer JM; Nagai T; van Seventer GA
    J Neuroimmunol; 2002 Dec; 133(1-2):60-71. PubMed ID: 12446009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of interleukin-12 p40 and p35 induction via Erk mitogen-activated protein kinase-dependent and -independent mechanisms and the implications for bioactive IL-12 and IL-23 responses.
    Goodridge HS; Harnett W; Liew FY; Harnett MM
    Immunology; 2003 Jul; 109(3):415-25. PubMed ID: 12807488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular adenine nucleotides modulate cytokine production by human monocyte-derived dendritic cells: dual effect on IL-12 and stimulation of IL-10.
    Wilkin F; Stordeur P; Goldman M; Boeynaems JM; Robaye B
    Eur J Immunol; 2002 Sep; 32(9):2409-17. PubMed ID: 12207325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E2 exacerbates collagen-induced arthritis in mice through the inflammatory interleukin-23/interleukin-17 axis.
    Sheibanie AF; Khayrullina T; Safadi FF; Ganea D
    Arthritis Rheum; 2007 Aug; 56(8):2608-19. PubMed ID: 17665454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro differentiation of dendritic cells in the presence of prostaglandin E2 alters the IL-12/IL-23 balance and promotes differentiation of Th17 cells.
    Khayrullina T; Yen JH; Jing H; Ganea D
    J Immunol; 2008 Jul; 181(1):721-35. PubMed ID: 18566439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential production of the IL-12(p40)/IL-23(p19) heterodimer by dendritic cells from human newborns.
    Vanden Eijnden S; Goriely S; De Wit D; Goldman M; Willems F
    Eur J Immunol; 2006 Jan; 36(1):21-6. PubMed ID: 16342235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E2 Inhibition of IL-27 Production in Murine Dendritic Cells: A Novel Mechanism That Involves IRF1.
    Hooper KM; Yen JH; Kong W; Rahbari KM; Kuo PC; Gamero AM; Ganea D
    J Immunol; 2017 Feb; 198(4):1521-1530. PubMed ID: 28062696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingosine-1-phosphate differently regulates the cytokine production of IL-12, IL-23 and IL-27 in activated murine bone marrow derived dendritic cells.
    Schaper K; Kietzmann M; Bäumer W
    Mol Immunol; 2014 May; 59(1):10-8. PubMed ID: 24434636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-23 production by cosecretion of endogenous p19 and transgenic p40 in keratin 14/p40 transgenic mice: evidence for enhanced cutaneous immunity.
    Kopp T; Lenz P; Bello-Fernandez C; Kastelein RA; Kupper TS; Stingl G
    J Immunol; 2003 Jun; 170(11):5438-44. PubMed ID: 12759419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells.
    Becker C; Wirtz S; Blessing M; Pirhonen J; Strand D; Bechthold O; Frick J; Galle PR; Autenrieth I; Neurath MF
    J Clin Invest; 2003 Sep; 112(5):693-706. PubMed ID: 12952918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.